In addition to melanoma, inactivating mutations in genes related to IFNγ signalling, in particular JAK1, have recently been described for microsatellite instable endometrial and colorectal cancers, arguing for a contribution to disease progression also in other malignancies32, 33, 34, 35, 36, 37. This evidence concerns the gene IFNG and colorectal cancer.